Humana Inc. (NYSE:HUM – Get Free Report) declared a quarterly dividend on Thursday, April 18th, RTT News reports. Stockholders of record on Friday, June 28th will be paid a dividend of 0.885 per share by the insurance provider on Friday, July 26th. This represents a $3.54 annualized dividend and a dividend yield of 0.99%. The ex-dividend date of this dividend is Friday, June 28th.
Humana has raised its dividend payment by an average of 12.3% annually over the last three years. Humana has a payout ratio of 17.3% indicating that its dividend is sufficiently covered by earnings. Analysts expect Humana to earn $19.63 per share next year, which means the company should continue to be able to cover its $3.54 annual dividend with an expected future payout ratio of 18.0%.
Humana Trading Down 0.6 %
Shares of Humana stock opened at $355.88 on Wednesday. The stock has a market cap of $42.88 billion, a P/E ratio of 22.16, a P/E/G ratio of 2.10 and a beta of 0.53. The stock’s 50 day simple moving average is $341.39 and its 200-day simple moving average is $354.08. Humana has a 1-year low of $298.61 and a 1-year high of $530.54. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.67 and a quick ratio of 1.67.
Analysts Set New Price Targets
Several research firms have recently commented on HUM. UBS Group reduced their price target on shares of Humana from $334.00 to $326.00 and set a “neutral” rating on the stock in a research report on Thursday, April 25th. Royal Bank of Canada cut their target price on Humana from $415.00 to $353.00 and set an “outperform” rating on the stock in a research report on Thursday, April 25th. Barclays lowered their target price on shares of Humana from $356.00 to $310.00 and set an “equal weight” rating for the company in a research note on Tuesday, April 2nd. Baird R W upgraded shares of Humana to a “hold” rating in a research note on Thursday, May 30th. Finally, Oppenheimer lowered their target price on shares of Humana from $415.00 to $370.00 and set an “outperform” rating for the company in a research note on Thursday, April 25th. Fourteen analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $410.47.
View Our Latest Research Report on Humana
About Humana
Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Read More
- Five stocks we like better than Humana
- How to Invest in Biotech Stocks
- Regis Corporation Stock Climbs 200%: Analyzing the Catalyst
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Carnival Cruise Stock Nears Analyst Forecasts on Strong Earnings
- What is the NASDAQ Stock Exchange?
- Occidental Petroleum: Buffett Causes OXY Stock Rebound
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.